PROCTER & GAMBLE HEALTH | SAMRAT PHARMA | PROCTER & GAMBLE HEALTH/ SAMRAT PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 5,848.0 | 0.6% | View Chart |
P/BV | x | 10.6 | 2.0 | 518.0% | View Chart |
Dividend Yield | % | 2.0 | 0.2 | 837.3% |
PROCTER & GAMBLE HEALTH SAMRAT PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
SAMRAT PHARMA Mar-23 |
PROCTER & GAMBLE HEALTH/ SAMRAT PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 1,250 | 429.2% | |
Low | Rs | 3,883 | 332 | 1,169.6% | |
Sales per share (Unadj.) | Rs | 740.7 | 1,005.3 | 73.7% | |
Earnings per share (Unadj.) | Rs | 138.2 | 53.8 | 256.8% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 55.9 | 277.6% | |
Dividends per share (Unadj.) | Rs | 95.00 | 1.00 | 9,500.0% | |
Avg Dividend yield | % | 2.1 | 0.1 | 1,625.0% | |
Book value per share (Unadj.) | Rs | 447.6 | 204.3 | 219.0% | |
Shares outstanding (eoy) | m | 16.60 | 3.09 | 537.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 0.8 | 793.5% | |
Avg P/E ratio | x | 33.5 | 14.7 | 227.6% | |
P/CF ratio (eoy) | x | 29.8 | 14.1 | 210.6% | |
Price / Book Value ratio | x | 10.3 | 3.9 | 266.9% | |
Dividend payout | % | 68.7 | 1.9 | 3,699.1% | |
Avg Mkt Cap | Rs m | 76,761 | 2,444 | 3,140.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 11 | 19,286.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 3,106 | 395.8% | |
Other income | Rs m | 184 | 5 | 3,847.3% | |
Total revenues | Rs m | 12,480 | 3,111 | 401.1% | |
Gross profit | Rs m | 3,247 | 239 | 1,357.0% | |
Depreciation | Rs m | 281 | 6 | 4,370.1% | |
Interest | Rs m | 8 | 12 | 62.5% | |
Profit before tax | Rs m | 3,142 | 225 | 1,394.6% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 59 | 1,436.1% | |
Profit after tax | Rs m | 2,295 | 166 | 1,379.8% | |
Gross profit margin | % | 26.4 | 7.7 | 342.8% | |
Effective tax rate | % | 27.0 | 26.2 | 103.0% | |
Net profit margin | % | 18.7 | 5.4 | 348.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 986 | 1,187.7% | |
Current liabilities | Rs m | 6,791 | 528 | 1,287.3% | |
Net working cap to sales | % | 40.0 | 14.8 | 271.1% | |
Current ratio | x | 1.7 | 1.9 | 92.3% | |
Inventory Days | Days | 263 | 8 | 3,266.4% | |
Debtors Days | Days | 343 | 602 | 57.1% | |
Net fixed assets | Rs m | 10,617 | 175 | 6,054.7% | |
Share capital | Rs m | 166 | 31 | 537.2% | |
"Free" reserves | Rs m | 7,265 | 601 | 1,209.7% | |
Net worth | Rs m | 7,431 | 631 | 1,176.8% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 1,162 | 1,922.5% | |
Interest coverage | x | 409.1 | 19.3 | 2,120.8% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 2.7 | 20.6% | |
Return on assets | % | 10.3 | 15.4 | 67.0% | |
Return on equity | % | 30.9 | 26.3 | 117.3% | |
Return on capital | % | 42.4 | 37.6 | 112.6% | |
Exports to sales | % | 0 | 4.1 | 0.0% | |
Imports to sales | % | 13.1 | 83.3 | 15.7% | |
Exports (fob) | Rs m | NA | 127 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 2,587 | 62.1% | |
Fx inflow | Rs m | 1,465 | 127 | 1,155.7% | |
Fx outflow | Rs m | 1,605 | 2,587 | 62.1% | |
Net fx | Rs m | -140 | -2,460 | 5.7% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | -94 | -2,500.8% | |
From Investments | Rs m | -215 | -30 | 715.5% | |
From Financial Activity | Rs m | -985 | 96 | -1,025.8% | |
Net Cashflow | Rs m | 1,160 | -28 | -4,081.3% |
Indian Promoters | % | 0.0 | 48.6 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 3.2 | 616.4% | |
FIIs | % | 6.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 51.4 | 93.8% | |
Shareholders | 56,778 | 7,478 | 759.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | SAMRAT PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 8.59% | 0.45% |
1-Month | -1.15% | 18.58% | 2.55% |
1-Year | 0.73% | -26.84% | 56.14% |
3-Year CAGR | -8.76% | 31.35% | 15.22% |
5-Year CAGR | 4.97% | 39.12% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the SAMRAT PHARMA share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of SAMRAT PHARMA the stake stands at 48.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of SAMRAT PHARMA.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
SAMRAT PHARMA paid Rs 1.0, and its dividend payout ratio stood at 1.9%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of SAMRAT PHARMA.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.